Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Mcap of 8 most valued firms surges by ₹1.90 trn, ICICI Bank shines
The combined market valuation of eight of the top-10 most valued firms surged by Rs 1.90 lakh crore last week, with ICICI Bank stealing the show, in tandem with a rally in equities. Last week, the BSE benchmark Sensex jumped 1,284.61 points, or 1.73 per cent, and the NSE Nifty surged 256.2 points, or 1 per cent. "Indian equity markets ended a volatile week on a strong note, snapping a two-week losing streak amid improving global sentiment and supportive measures from the Reserve Bank of India (RBI) aimed at attracting foreign currency inflows," Ajit Mishra, SVP, Research, Religare Broking Ltd, said. Investor confidence improved on optimism surrounding a potential USIran peace deal, which raised hopes of easing geopolitical tensions and stabilising energy markets, he added. From the top-10 pack, Reliance Industries, HDFC Bank, Bharti Airtel, ICICI Bank, State Bank of India, Bajaj Finance, Larsen & Toubro and Hindustan Unilever were the winners, while Tata Consultancy Services (TCS)
Reebok sales doubled in last 3 yrs, aggressive on growth trajectory: Aditya Birla Lifestyle Brands
Reebok's sales have more than doubled in India over the last three years following its acquisition by an Aditya Birla group firm. The brand plans to aggressively expand its network by adding 40-50 stores annually, targeting untapped market opportunities across metro and smaller towns. This growth is fueled by strong same-store sales and new product launches.
Nifty, Sensex to rally more on Monday? Iran peace deal among 5 factors to dictate Dalal Street this week
Indian benchmark indices rebounded sharply on Friday, with the Sensex and Nifty rising nearly 2%, driven by hopes of a US-Iran peace deal, cooling crude oil prices, and stronger global sentiment. The rally added around Rs 10 lakh crore to investors' wealth, taking the total market capitalisation of BSE-listed firms to Rs 462 lakh crore.
INR surges amid sharp pull back in oil prices; Sensex and Nifty jump by around 2%
The Indian rupee surged 67 paise to close at 95.18 (provisional) against the greenback on Friday as global oil prices fell sharply after US President Donald Trump indicated an imminent deal with Iran. A firm trend in domestic equity markets and a weaker American currency also supported the rupee during the day. Indian shares closed Friday's session on a buoyant note in a broad-based rally, with both frontline and broader market indexes posting sharp gains. The BSE Sensex settled at 75,527.95, surging 1,695.40 points (2.30%), and the NSE Nifty50 ended at 23,622.90, climbing 461.30 points (1.99%). Trump has reportedly said a deal to end the war with Iran is nearly complete, and is expected to be signed over the weekend in Europe, as he called off military strikes on the Islamic Republic hours after threatening to take control of its oil industry.
Vodafone Idea shares jump 4%; KM Birla says telco navigated through one of its toughest challenges in history
Vodafone Idea shares climbed after shareholders approved a Rs 4,730 crore investment from the Aditya Birla Group, signalling renewed promoter confidence. With funding support, easing AGR pressure and improved ratings, investor focus now shifts to execution, network expansion and the company’s long-term turnaround prospects.
Lloyds Metals & Energy Ltd Surges 3.16%, BSE Metal index Gains 1.84%
Lloyds Metals & Energy Ltd has lost 1.23% over last one month compared to 2.79% fall in BSE Metal index and 0.13% rise in the SENSEX
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
Exclusive | Why BSE wants options traders to think beyond the next expiry
After successfully reviving Sensex derivatives, BSE CEO Sundararaman Ramamurthy is now focused on shifting traders from weekly options to longer-dated contracts. Over the next three years, the exchange aims to boost participation in monthly and farther-expiry options, which it believes provide better hedging and help reduce market volatility during global shocks.
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.
INR pares initial losses and settles largely unchanged
The Indian rupee was largely flat and settled almost unchanged at Rs 95.43 per dollar, down just 2 paise on Wednesday, amid likely intervention from the Reserve Bank of India (RBI) to curb excessive volatility and prevent a further slide in the domestic unit. Rupee pared its initial losses as crude oil prices and the US dollar index retreated from their elevated levels. Indian shares gave up early gains to end little changed on Wednesday as investors weighed rising U.S.-Iran tensions and awaited key U.S. inflation data later in the day for fresh insights into market expectations for future interest rates in the face of rising energy-driven inflation risks. The BSE Sensex ended the day at 73,983.18, up by 64.42 points (0.09%), while the NSE Nifty 50 settled at 23,214.95, slipping by 27.15 points (-0.12%).
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.